非对称性二甲基精氨酸——慢性肾功能不全患者心血管并发症新的预测因子
摘要
慢性肾功能不全时血浆ADMA水平明显升高,慢性肾病患者其心血管并发症及其死亡率与ADMA水平具有明显相关性,ADMA可作为慢性肾功能不全患者心血管并发症新的预测因子。ADMA/DDAH系统可能成为心血管疾病防治的新靶点。
出处
《国外医学（泌尿系统分册）》
2005年第5期647-650,共4页
Foreign Medical Sciences(Urology and Nephrology Foreign Medical Sciences)
参考文献33
-
1Landmesser U, Hornig B, Drexler H, et al. Endothelial function:acritical determinant in atherosclerosis? Circulation, 2004, 329 (Suppl 1 ): Ⅱ27-Ⅱ33.
-
2Gokce N, Keaney JF, Hunter LM, et al. Predictive value of noninvasively determined endothelial dysfunction forlong- term cardiovascular events in patients with peripheralvascular disease. J Am Coll Cardiol, 2003, 41(10): 1769 - 1775.
-
3Vallance P,Leone A,Calver A,et al. Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet, 1992,339(8793):572 - 575.
-
4Kielstein JT, Impraim B, Simmel S, et al. Cardiovascular effects of systemic NO synthase inhibition with asymmetric dimethylarginine in humans. Circulation,2004,109(2): 172 - 177.
-
5Achan V, Broadhead M, Malaki M, et al. Asymmetric dimethylarginine causes hyperten sion and cardiac dysfunction in hunans and is actively metabolized by dimethylarginine dimethylaminohydrolase. Arterioscler Thromb Vasc Biol,2003,23(8):1455 - 1459.
-
6Xiao S, Wagner L, Schmidt RJ, et al. Circulating endothelial nitric oxidesynthase inhibitory factor in some patients with chronic renal disease.Kidney Int,2001,59(4): 1466 - 1472.
-
7Siroen MP, van der Sijp JR,Teerlink T, et al. The human liver clears both asymmetric and symmetric dimethylarginine. Hepatology, 2005, 41 ( 3 ):559 - 565.
-
8Zoccali C, Bode- Boger S, Mallamaci F, et al. Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end - stage renal disease: a prospective study. Lancet, 2001, 358 (9299): 2113 -2117.
-
9Martens - Lobenhoffer J, Krug O, Bode - Boger SM. Determination of arginine and asymmetric dimethylarginine(ADMA) in human plasma by liquid chromatography/mass spectrometry with the isotope dilution technique. J Mass Spectrom,2004,39(11): 1287 - 1294.
-
10Fleck C,Schweitzer F,Karge E,et al. Serum concentrations of asymmetric (ADMA) and symmetric(SDMA) dimethylarginine in patients with chronic kidney diseases. Clinica Chimica Acta,2003,336(1 -2):1 - 12.
二级参考文献9
-
1Kielstein JT, Bode-Boger SM, Frolich JC, et al. Relationship of asymmetric dimethylarginine to dialysis treatment and atherosclerotic disease[J]. Kidney Int, 2001,59(suppl 78):S9-13.
-
2Bode-Boger SM, Boger RH, Kienke S, et al. Elevated L-arginine/dimethylarginine ratio contributes to enhanced systemic NO production by dietary L-arginine in hypercholesterolemic rabbits[J]. Biochem Biophys Res Commun, 1996,219:598-603.
-
3Wever R, Boer P. Nitric oxide production is reduced in patients with chronic renal failure[J]. Arterioscler Thromb Vasc Biol, 1999,19:1168-1172.
-
4Wahbi N, Dalton RN. Dimethylarginines in chronic renal failure[J]. J Clin Pathol, 2001,54:470-473.
-
5Vallance P, Lenone A, Calver A, et al. Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure[J]. Lancet, 1992,339:572-575.
-
6Macallister RJ, Whitley GS, Vallance P, et al. Effects of guanidino and uremic compounds on nitric oxide pathways[J]. Kidney Int, 1994,45:737-742.
-
7Marescau B, Nagels G, Possemiers I, et al. Guanidino compounds in serum and urine of nondialyzed patients with chronic renal insufficiency[J]. Metobolism, 1997,46:1024-1031.
-
8Miyazaki H, Matsuoka H, Cooke JP, et al. Endogenous nitric oxide synthase inhibitor: A novel marker of atherosclerosis[J]. Circulation, 1999,99:1141-1146.
-
9Peters H, Bopder WA, Noble NA. L-Arginine supplementtation increases mesangial cell injury and subseqent tissue fibrosis in experimental glomerulonephritis[J]. Kidney Int, 1997,55:2264-2273.
共引文献12
-
1施蓓莉,倪兆慧.ADMA在慢性肾脏疾病患者并发心血管疾病中的作用[J].心血管病学进展,2006,27(z1):63-65. 被引量：1
-
2陈景开,王霄,陈满清,赵秋良,吴刚勇,张丽,张维维.高血压患者血清不对称二甲基精氨酸和同型半胱氨酸的变化及其与血压相关性的探讨[J].中国微循环,2006,10(6):434-436. 被引量：2
-
3陈景开,王霄,赵秋良,陈满清,吴刚勇,张维维,张丽.吸烟对冠心病患者血清不对称二甲基精氨酸的影响[J].东南国防医药,2007,9(1):1-2. 被引量：4
-
4陈景开,王霄,陈满清,赵秋良,吴刚勇,张丽,张维维.冠心病患者不对称二甲基精氨酸和同型半胱氨酸对一氧化氮合酶和一氧化氮的影响[J].中国微循环,2007,11(2):125-127. 被引量：2
-
5陈景开,王霄,赵秋良,吴刚勇,陈满清,张维维,张丽.离退休老干部血清不对称二甲基精氨酸和同型半胱氨酸的变化及其意义[J].东南国防医药,2007,9(2):81-83.
-
6陈景开,陈满清,赵秋良,吴刚勇,张丽,张维维,王霄.叶酸对冠心病患者不对称二甲基精氨酸和同型半胱氨酸的影响[J].中国微循环,2007,11(3):203-205. 被引量：1
-
7陈景开,吴刚勇,陈满清,赵秋良,王霄,张维维,张丽.老年人血清不对称二甲基精氨酸与同型半胱氨酸及动脉硬化其他危险因素的相关性分析[J].东南国防医药,2007,9(4):243-245. 被引量：2
-
8何雅億,李瑛,刘伏友.非对称性二甲基精氨酸与慢性肾脏疾病[J].中国中西医结合肾病杂志,2008,9(10):923-926.
-
9孙坚军.ADMA与肾脏病的心血管疾病[J].国际泌尿系统杂志,2004,24(S1):98-101. 被引量：1
-
10何显菁,廖树森.非对称性二甲基精氨酸与心血管疾病关系的研究进展[J].实用心脑肺血管病杂志,2016,24(3):1-3. 被引量：7
-
1周光,杜业亮,孙长庆,王法欣,焦迎辉.颈动脉狭窄与ADMA的相关性研究[J].疑难病杂志,2009,8(12):728-729.
-
2吴婕,顾晔,成忠,邹武松,叶顺传.冠状动脉支架置入术对急性冠状动脉综合征患者血浆非对称二甲基精氨酸水平的影响[J].临床心血管病杂志,2011,27(5):338-340. 被引量：2
-
3沈行良.一氧化氮与阳痿[J].海南医学院学报,2000,6(4):253-256.
-
4张波（摘译）.慢性肾脏疾病患者的冠状动脉钙化、ADMA与胰岛素抵抗[J].中华医学信息导报,2008,23(20):8-8.
-
5何雅億,李瑛,刘伏友.非对称性二甲基精氨酸与慢性肾脏疾病[J].中国中西医结合肾病杂志,2008,9(10):923-926.
-
6罗洁(综述),白云凯(审校).非对称性二甲基精氨酸：慢性肾病患者动脉粥样硬化的中介调解物？[J].国际泌尿系统杂志,2010,30(6):830-832.
-
7何畔,梁珊.非对称性二甲基精氨酸在急性脊髓损伤患者治疗前后的变化[J].中华急诊医学杂志,2010,19(4):401-404.
-
8陈晨,王金桃,丁玲.脑梗死应用促红细胞生成素治疗可能无效[J].中华医学杂志,2013,93(33):2636-2636. 被引量：1
-
9韩雪,张东亮,刘文虎.ADMA加速慢性肾脏疾病肾功能损伤的研究新进展[J].临床和实验医学杂志,2011,10(8):630-631.
-
10危正南,张庆红,吴东,杨红荣.高通量血液透析对尿毒症患者血浆毒素分子含量及机体微炎症状态的影响[J].海南医学院学报,2016,22(6):558-561. 被引量：47
